Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

March 31, 2005

Conditions
HIV InfectionsLipodystrophyWasting Disease
Interventions
DRUG

Abacavir sulfate

DRUG

Atazanavir/Ritonavir

DRUG

Lopinavir/Ritonavir

DRUG

Nevirapine

Trial Locations (25)

10003

Beth Israel Med. Ctr., ACTU, New York

10016

NY Univ. HIV/AIDS CRS, New York

19104

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

37203

Vanderbilt Therapeutics CRS, Nashville

60611

Northwestern University CRS, Chicago

60612

Rush Univ. Med. Ctr. ACTG CRS, Chicago

63108

St. Louis ConnectCare, Infectious Diseases Clinic, St Louis

Washington U CRS, St Louis

80262

University of Colorado Hospital CRS, Aurora

90095

UCLA CARE Center CRS, Los Angeles

96816

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

432101228

The Ohio State University Medical Center, Columbus

775550435

Univ. of Texas Medical Branch, ACTU, Galveston

90502-2052

Harbor-UCLA Med. Ctr. CRS, Torrance

Unknown

Cook County Hosp. CORE Ctr., Chicago

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

Indiana Univ. School of Medicine, Wishard Memorial, Indianapolis

Methodist Hosp. of Indiana, Indianapolis

SSTAR, Family Healthcare Ctr., Fall River

Rhode Island Hosp., Providence

02215

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

55455-0392

University of Minnesota, ACTU, Minneapolis

45267-0405

Univ. of Cincinnati CRS, Cincinnati

44109-1998

MetroHealth CRS, Cleveland

02906

The Miriam Hosp. ACTG CRS, Providence

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00028314 - Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients | Biotech Hunter | Biotech Hunter